Apogee Therapeutics, Inc. (APGE) — Stock Price, Chart & Analysis
Apogee Therapeutics, Inc. (APGE) is a Healthcare stock currently trading at $134.84, up 0.26% on the day. It carries a market capitalization of $10.20B. Over the past 52 weeks, APGE has traded between $34.40 and $134.88. Apogee Therapeutics, Inc. does not currently pay a regular dividend. View the live APGE chart, technical opinion, analyst ratings, fundamentals and latest news below.
Apogee Therapeutics, Inc. (APGE) key data
| Price | $134.84 |
| Change (today) | +0.26% |
| Previous close | $134.49 |
| Market cap | $10.20B |
| EPS (TTM) | $-4.34 |
| 52-week high | $134.88 |
| 52-week low | $34.40 |
| Beta | 0.34 |
| Avg. volume | 2.71M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Apogee Therapeutics, Inc. (APGE)
How much does one share of Apogee Therapeutics, Inc. cost?
As of the latest update, one share of Apogee Therapeutics, Inc. (APGE) trades at $134.84 (+0.26% today).
What is Apogee Therapeutics, Inc.'s market cap?
Apogee Therapeutics, Inc. has a market capitalization of approximately $10.20B.
What is Apogee Therapeutics, Inc.'s earnings per share (EPS)?
Apogee Therapeutics, Inc.'s trailing twelve-month EPS is $-4.34.
Does Apogee Therapeutics, Inc. pay a dividend?
Apogee Therapeutics, Inc. does not currently pay a regular dividend.
What is Apogee Therapeutics, Inc.'s 52-week trading range?
Over the past year, APGE has traded between $34.40 and $134.88.
What is the analyst price target for Apogee Therapeutics, Inc.?
The mean analyst price target for Apogee Therapeutics, Inc. is $130.53. This is informational only and not investment advice.
Latest Apogee Therapeutics, Inc. (APGE) news
- AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's ChangedNews · Aug 7, 2026
- Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie BuyoutNews · Aug 5, 2026
- Sector Update: Healthcare Stocks Softer Late AfternoonNews · Aug 4, 2026
- Merck, Pfizer Lift Full-Year Sales Outlooks Following Second-Quarter BeatsNews · Aug 4, 2026
- Is Apogee Therapeutics (APGE) Fully Priced, Or Still A Bargain?News · Aug 3, 2026
- ABBV Q2 Earnings Call Balances Growth With Apogee DilutionNews · Aug 3, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live APGE dashboard…